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Introduction: Health-related quality of life (HRQoL) in patients treated in intensive care has been reported to be
lower compared with age- and sex-adjusted control groups. Our aim was to test whether stratifying for coexisting
conditions would reduce observed differences in HRQoL between patients treated in the ICU and a control group
from the normal population. We also wanted to characterize the ICU patients with the lowest HRQoL within these
strata.
Methods: We did a cross-sectional comparison of scores of the short-form health survey (SF-36) questionnaire in a
multicenter study of patients treated in the ICU (n = 780) and those from a local public health survey (n = 6,093).
Analyses were in both groups adjusted for age and sex, and data stratified for coexisting conditions. Within each
stratum, patients with low scores (below −2 SD of the control group) were identified and characterized.
Results: After adjustment, there were minor and insignificant differences in mean SF-36 scores between patients
and controls. Eight (n = 18) and 22% (n = 51) of the patients had low scores (−2 SD of the control group) in the
physical and mental dimensions of SF-36, respectively. Patients with low scores were usually male, single, on sick
leave before admission to critical care, and survived a shorter time after being in ICU.
Conclusions: After adjusting for age, sex, and coexisting conditions, mean HRQoL scores were almost equal in
patients and controls. Up to 22% (n = 51) of the patients had, however, a poor quality of life as compared with the
controls (−2 SD). This group, which more often consisted of single men, individuals who were on sick leave before
admission to the ICU, had an increased mortality after ICU. This group should be a target for future support.Introduction
Health-related quality of life (HRQoL) has been reported
to be significantly worse among patients who have been
treated in intensive care units (ICUs) than among the gen-
eral population [1,2]. Many factors have been claimed to
have important effects on this, usually ICU related [1]. Re-
cently increasing evidence supports the idea that coexist-
ing medical conditions may be important, and possibly the
main factor in reducing HRQoL among patients who have
been treated in an ICU [3,4]. It must then be appreciated
that older age and the presence of coexisting conditions* Correspondence: lotti.orvelius@lio.se
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reproduction in any medium, provided the orare more common among patients who have been treated
in ICUs [3,5-7] than in their control groups. Although
many patients in ICU have one other disease, the relative
contributions among those with more than one condition
is considerable [3].
Control groups, in these studies, usually comprised pa-
tients either in hospital or living at home. The latter
group is usually used, and they are more often young
and with few coexisting conditions [4]. The high inci-
dence of coexisting conditions in patients in ICUs raises
the question of how these can influence the evaluation
of HRQoL after critical care. More precisely, what is the
magnitude of the difference in HRQoL in patients previ-
ously treated in ICU compared with that of a control
group also stratified for coexisting disease? Such a con-
trol group has not, as far as we know, been used in such
an evaluation.al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tients who had been in the ICU with that of a reference
group gathered from the uptake areas of the hospitals
participating in the study and, in addition to adjusting
data for age and sex, also to stratify for coexisting dis-
ease. Our hypothesis was that after such stratification,
the magnitude of the difference in HRQoL between ICU
patients and controls would be less than previously
shown. As also the general population has a wide vari-
ation in HRQoL, with SF-36 scores ranging from 0 to
100, we a priori also defined the lower limit of normal
HRQoL at −2 standard deviations (SDs) below the mean
SF-36 score of the comorbidity stratified value of the
age- and sex-adjusted control group (30).
In addition, we wanted to identify the proportion of pa-
tients with poor HRQoLs and to assess their characteristics.
In accordance with our prestudy hypothesis, our main
findings were; first, the differences in HRQoL between
the ICU patients and the general reference group were
significantly decreased after adjusting for age and sex,
and stratified for coexisting disease. Second, up to 22%
of the patients had an HRQoL level below the reference
group (−2 SD). Last, risk factors for HRQoL below the
reference group were being single and male, having a
sick leave before ICU admission, and increased mortality
early after ICU.Material and methods
We used a cross-sectional analysis to compare data from
a multicenter study of patients who had been in an ICU
in the southeast of Sweden, the “Livskvalitet Intensiv-
vård” (LIVA) study [3], with data from a control group
from a public health survey of a normal population [8].Study group
Data from former ICU patients were collected in the
LIVA study, from 2000, and completed during 2004. The
aim of that study was to measure and describe HRQoL
among former patients from the ICU after discharge
from hospital. These results have been published both in
the short term (6 months) [4], for separate diagnoses
such as trauma [9], and longitudinally (up to 3 years)
[3]. In the previous studies, comorbidity stratification
has not been performed, in either the study group or in
the controls.
The ICUs included in the study were in one university
and two general hospitals, each of which admitted 500
to 750 ICU patients annually. Of these admissions during
the study, 93% were emergencies, and the most common
primary diagnoses were sepsis, multiple trauma, and dis-
turbances in the respiratory or circulatory systems, or both.
Patients with primary coronary disease, those recovering
from heart surgery, neurosurgical patients, neonates, andpatients with burns are treated at other specialized units
and were excluded.
All patients aged between 20 and 74 years who were
admitted consecutively between 1 August 2000 and 30
June 2004, who remained in the ICU for more than
24 hours, who were alive 6 months after discharge from
hospital, and who consented to participate in the study,
were included. The upper age limit was chosen to match
the age of the control group (20 to 74 years). Patients
who were readmitted were included only on their first
admission. The national Swedish Social Security register
was checked to avoid sending inquiries to patients who
had died. Six months after discharge from the ICU, we
sent information and a request to participate to each pa-
tient by mail, together with a structured questionnaire
and a preaddressed and prepaid envelope. Patients who
had not responded within about 10 days were contacted
by telephone by one of the investigators (LO). If telephone
or first mailing achieved no answer, two reminders were
sent (at 3 and 6 weeks).
All admissions to ICU at all hospitals are recorded
electronically in databases. From these databases, data
were extracted about patients’ sex, age, reasons for ad-
mission to and duration of stay in ICU, APACHE II
score on admission, and outcome (dead or alive).
Control group
Data from a questionnaire-based public health survey of
the population of the county of Östergötland (the area
in which the university hospital is situated and adjacent
to the county where the general hospital is located) were
used for the reference group [8]. That survey aimed at
monitoring health and health-related risk factors in the
population and was completed during the year 1999.
Questionnaires were mailed to a random sample of 10,00
people aged 20 to 74 years. After two reminders, 6,093
(61%) had responded. Apart from lower percentages of
immigrants and single households, the responders differed
only marginally from the reference population of the
county [8].
The study was approved by the Committee for Ethical
Research at the University of Health in Linköping.
Questionnaires and instruments
In both datasets, the instrument chosen for the evalu-
ation of HRQoL was the medical outcome Short Form
health survey (SF-36) version 1 [10]. SF-36 is well known
internationally and has been recommended for measur-
ing HRQoL in critical care [11]. It is reliable and valid
for use in the ICU [12,13] and has been translated into
Swedish and validated in a representative sample [14]. It
has 36 questions and generates a health profile of eight
subscales: physical functioning (PF), limitation of the
role by physical problems (RP), bodily pain (BP), general
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tion of the role by emotional problems (RE), and mental
health (MH) [14]. The scores on all the subscales are
transformed to a scale from 0 = worst to 100 = best [15].
In both groups, coexisting conditions were assessed
from self-reports of present disease, as previously de-
scribed [3,4,9,16]. In the ICU questionnaire, the ques-
tionnaire asked, “Do you have any of the following
diseases and have had it for more than 6 months prior
to admission to the ICU?” with the prespecified alterna-
tives of cancer; diabetes; heart failure; asthma/allergy;
rheumatic, gastrointestinal, blood, kidney, psychiatric, or
neurologic disease; thyroid or any other metabolic dis-
turbance; or other long-term disease?” Information was
also collected about participants’ civil status, employ-
ment before and after admission to the ICU, educational
level, and self-reported sick leave before they were ad-
mitted to the ICU.
The control-group questionnaire included, apart from
questions on background characteristics, a wide array of
questions about health problems. These questions assessed
the frequency (daily, weekly, monthly, and rarely/never) of
specific symptoms of ill health during the previous
12 months, some of which were specific to certain health
problems and diseases such as asthma and cardiovascular
disease. Also, this section of the survey was concluded
with an open question that asked about “other health
problems.” Although different from the questions used to
assess preexisting disease in the ICU patients, the ques-
tions on health problems made it possible to classify the
reference population into disease groups corresponding to
those reported by the ICU patients. This was done in the
following way. One of the authors (MK, MD) transformed
the free-text information regarding such “other health
problems,” which were basically of two categories; one was
Latin names of diagnoses, which were well defined; the
other was, to a large extent, symptoms, from the Inter-
national Classification of Diseases-10 nomenclature.
Milder symptoms (low intensity and infrequent) were
overlooked. Classification of the reference group into
disease-specific subgroups was based on symptoms re-
ported as daily or weekly on one or more questions within
the same disease category, or the International Classi-
fication of Diseases-10 labels put on the “other health
problems” reported. As no questions about symptoms of
cancer and diabetes were included in the questionnaire,
the cancer and diabetes subgroups were based solely on
the second question, whereas the other disease-specific
subgroups (cardiovascular disease, gastrointestinal disease,
and asthma) were based on either one, or a combination
of the two. In the majority of cases, the classification of
respondents having a disease was based only on the in-
formation from the open-ended question (mainly Latin
diagnoses).Statistical analysis
Descriptive data are presented as mean (SD), range, and
percentage. The patients and the control group were
each divided into three groups for coexisting conditions/
other conditions: those who had previously been healthy
(that is, they had had no disease before they were admit-
ted to the ICU (for the reference groups, no disease)),
those who had one coexisting disease, and those who
had more than one.
Within each stratum, models were built on a linear re-
gression analysis for the control group. Scores for each
dimension of SF-36 were used as dependent variables
one at a time, and the independent variables were age
and sex, according to general conventions. The specified
model was then applied to the patient’s model, and a
predicted dimension was calculated based on the pa-
tient’s age and sex. In the model, we used the mean
value for each of the eight SF-36 dimensions adjusted
for age, sex, and coexisting condition.
The predicted values for patients were then compared
with the −2 SD value for the control group, for each
stratum. Those patients who had lower predicted values
than the limit for the controls were considered to be
outside the “reference range.”
Probabilities of <0.05 were accepted as significant.
Statistical analyses were aided by the use of the Statistical
Package for the Social Sciences (SPSS, named PASW from
version 18.0; Chicago, IL, USA).
Results
Of the 5,306 patients admitted during the study period,
780 were eventually included in this study. The reasons
for exclusions and number of patients in the three
groups are shown in the flow chart (Figure 1). The pro-
portion of patients discharged alive from ICU who were
alive at 6 months after ICU care and who did provide a
response was 53%. Clinical and personal details of the
patients are shown in Table 1 and, for the control group,
in Table 2.
The group who did not respond at all in the study
(n = 683) differed from the group who responded, in
that there were fewer men (P = 0.02), higher average
APACHE II score (P = 0.04), shorter LoS in the ICU
(P < 0.001), shorter time on ventilator (P < 0.001), and
fewer of the following admission diagnoses to ICU
(multitrauma, sepsis, and gastrointestinal disease P <
0.001).
The mean age of the patients from ICU was lower
(46 years; SD, 15.8) than that of the controls (53 years; SD,
15.1) (P < 0.001). There was also a significant sex differ-
ence, with more men in the ICU group (57%, n = 444)
than in the control group (46%, n =2,8882) (P < 0.001).
The prevalence of coexisting/present disease was higher
among the ICU patients than the control group, being
Patients admitted to the ICU
during the study period
(n=5306)
Excluded (n=2920)
< 18 years (n=537)
> 74 years (n=200)
< 24 hours (n=2183)
Patients assessed for 
eligibility (n=2386)
Excluded (n=923)
Died in the ICU (n=265)
Died in hospital (n=367)
Died after discharge <6 months (n=150)
Patients readmitted to ICU (n= 141)
Alive 6 months after 
discharge (n=1463)




Participated at 6 
months age 18-74 
(n=780)










Figure 1 Outline of the protocol of the study.
Orwelius et al. Critical Care 2013, 17:R236 Page 4 of 12
http://ccforum.com/content/17/5/R23670% (n = 546) and 28% (n = 1,707), respectively (P < 0.001).
This was also the case for prevalence of more than one
disease; patients n = 230, 30%; control group n = 296, 5%
(data not shown).
SF-36 scores for patients from ICU and the control group
SF-36 scores for the whole ICU group and the control
group are shown in Figure 2A. The differences between
the two groups in all eight dimensions were large and
significant (P < 0.001 in each case).
In Figure 2B, the SF-36 scores for the patients have
been adjusted for age and sex, which leads to a pro-
nounced reduction in the differences from the control
group in all dimensions. When stratified for the number
of coexisting conditions (healthy, one disease, and more
than one disease), the remaining differences are further
diminished, and the small differences recorded between
the patients and the control groups are not significant
for any dimension in any of the strata (Figure 3A-C).Patients with low SF-36 scores
In Table 3, the number and percentages of patients who
had scores below a limit regarded as low (−2 SD of the
reference group) are shown for the patients with no
coexisting conditions (n = 234), one coexisting condition
(n = 316), and more than one coexisting condition (n =
230). The largest percentage of low scores in the physical
dimensions was 8% (n = 18) and was seen for physical
functioning in the strata with no coexisting condition. In
the psychosocial dimensions (vitality, social functioning,
emotional problems, and mental health), the highest per-
centage of low scores was 22% (n = 51); this was seen for
emotional role function in the stratum with more than
one coexisting condition.
Characteristics of patients with low (−2 SD) SF-36 scores
Compared with other patients, those with low SF-36
scores were more likely to be male, single, and on sick
leave before admission to the ICU (P < 0.001) (Tables 4









(n = 780) Range (n = 234) Range (n = 316) Range (n = 230) Range
No of men/
women (%)
444/336 (56.9) 131/103 (56.0) 181/135 (57.3) 132/98 (57.4)
Age (years) 46.4 (15.8) 52.5 (15.8) 48.0 (17.3) 18–74 52.9 (15.2) 19–74 56.4 (14.0) 19–74
APACHE II score 14.8 (7.6) 0-43 12.7 (7.1) 0–34 15.2 (7.5) 0–42 16.6 (7.9) 0–43
Stay in ICU
(hours)
129.9 (178.6) 24–1845 100.9 (112.2) 24–665 135.3 (182.2) 24–1,170 152.0 (220.5) 24–1,845
Stay in hospital
(days)
14.8 (20.3) 1–231 11.9 (14.4) 1–115 15.4 (19.6) 1–124 16.9 (25.4) 1–231
Time on
ventilator (hours)












APACHE II, Acute Physiology and Chronic health Evaluation; ICU, Intensive Care Unit.
Data are expressed as mean (SD) or N (%), unless otherwise stated.
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after discharge from the ICU (6 months to 3 years)
(Table 6). Besides these mortality-dependent changes,
we found no effects related to social factors, such as
marital state, employment, and education between pa-
tients who died within the time period 6 months toTable 2 Clinical details of the control group
Total study group No comorbidity
(n = 6093) Range (n = 4386) R
No of men/women (%) 2,822/3,271 (46.3) 2,067/2,319 (47.1)







No. of diseases (%)
0 4,386 (72.0)
1 1,411 (23.2)
>1 296 (4.9)3 years and who had either a low or normal level of
HRQoL (Table 7).
Discussion
Several new and important findings resulted from this
study.Comorbidity 1 disease Comorbidity >1 disease
ange (n = 1411) Range (n = 296) Range
630/781 (44.6) 125/171 (42.2)


































ICU patients at 6 months
(n=780)
Figure 2 Health-related quality-of-life differences between the reference group and ICU patients not adjusted for age and sex
respectively adjusted for age and sex. (A) Health-related quality of life (SF-36) values shown for each dimension: physical functioning (PF), role
limited by physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limited by emotional problems
(RE), and mental health (MH) in the Polar Plot Chart for the reference group (n = 6,093) and patients from ICU (n = 780), not adjusted for age and
sex. (B) Health-related quality of life (SF-36) values shown for each dimension: physical functioning (PF), role limited by physical problems (RP),
bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limited by emotional problems (RE), and mental health (MH) in the
Polar Plot Chart for the reference group (n = 6093) and patients from the ICU (n = 780), adjusted for age and sex.
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found that after stratifying for coexisting disease, no dif-
ferences were found in HRQoL between patients who
had been in an ICU and those in a control group
matched for age and sex [1,2]. These conclusions are
supported by our previous findings that, after adjusting
for coexisting conditions, only minor effects on HRQoL
could be related to specific events in ICU, such as high
APACHE II score, longer duration of stay, and time
spent on a ventilator [3].
Second, and of particular importance for this study, is
that after adjusting for age and sex, we used the lower −2
SD cut-off value of the control group (HRQoL) as the
lower norm for HRQoL for each of the groups (healthy,
one disease, and more than one disease). To our know-
ledge, this has not been attempted before for ICU-
related research. In doing so, we aimed to find the lowerreference limit of HRQoL of people in Swedish society
with whom to compare the patients who had been in an
ICU. By assessing this limit, we aimed to study those pa-
tients who constitute the group that have a problem re-
lated to HRQoL.
Third, 6 months after discharge from ICU, up to 22%
(n = 51) of the patients have a perceived HRQoL lower
than the worst −2 SD of a normal population. These pa-
tients were more likely to be male, single, have been on
sick leave before they were admitted to the ICU, but also
survived a shorter time (6 months to 3 years) after their
stay in the ICU. As this is an important finding, it un-
derlines that these patients should be identified and the
underlying factors further explored. The result that their
decline was mainly recorded in the mental-dimensions
contrasts with findings in previous studies in which the



















































ICU patients at 6 months
(n=230)
Figure 3 Health-related quality-of-life differences between the reference group and ICU patients without preexisting diseases, with
one preexisting disease, and more than one preexisting disease, respectively. (A) Health-related quality of life (SF-36) values shown for
each dimension: physical functioning (PF), role limited by physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social
functioning (SF), role limited by emotional problems (RE), and mental health (MH) in the Polar Plot Chart for the healthy reference group
(n = 4,386) and the previously healthy ICU patients (n = 234), adjusted for age and sex. (B) Health-related quality of life (SF-36) values shown for
each dimension: physical functioning (PF), role limited by physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social
functioning (SF), role limited by emotional problems (RE), and mental health (MH) in the Polar Plot Chart for the reference group (n = 1,411), and
the patients from ICU (n = 316) with one preexisting disease, adjusted for age and sex. (C) Health-related quality of life (SF-36) values shown for
each dimension: physical functioning (PF), role limited by physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social
functioning (SF), role limited by emotional problems (RE), and mental health (MH) in the Polar Plot Chart for the reference group (n = 296) and
the patients from ICU (n = 230) with more than one preexisting disease, adjusted for age and sex.
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Table 3 Proportions of the ICU patients with SF-36 score
2 SD below the reference group lower level, adjusted for
age and sex
Number (%) Mean Range
Without comorbidity (n= 234)
Physical function 18 (8.0) 27.6 6.9–39.1
Role functioning-physical 0
Bodily pain 2 (0.8) 9.2 5.9–12.5
General health 6 (2.6) 22.1 11.0–31.8
Vitality 19 (8.1) 9.9 −13.9–19.6
Social functioning 19 (8.1) 26.7 −2.47–37.5
Role function-emotional 31 (13.2) −5.7 −7.77– –2.10
Mental health 14 (6.0) 23.1 −2.69–35.2
Comorbidity 1 disease (n= 316)
Physical function 5 (1.6) 12.5 10.3–13.4
Role functioning-physical 0
Bodily pain 10 (3.2) 4.64 −3.06–10.5
General health 2 (0.6) 10.5 6.67–14.4
Vitality 23 (7.3) −3.65 −13.3–4.40
Social functioning 34 (10.8) 14.4 −4.33–25.0
Role function-emotional 40 (12.6) −1.72 −1.98– –1.59
Mental health 24 (7.6) 11.5 −6.06–19.6
Comorbidity >1 disease (n = 230)
Physical function 0
Role functioning-physical 7 (3.0) −4.06 −9.32– –0.58
Bodily pain 11 (4.8) 5.75 0.70–9.60
General health 0
Vitality 15 (6.5) −1.87 −7.48–2.59
Social functioning 25 (10.9) 6.22 −4.62–11.7
Role function-emotional 51 (22.2) −3.83 −5.10– –3.14
Mental health 28 (12.2) 6.71 −17.8–24.0
Mean and range are data for the values of SF-36 scores of the patients that
were found to be below the −2 SD level of the reference group.
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to posttraumatic stress.
Fourth, a strength of this study is that the people stud-
ied in both groups are representative of general Swedish
conditions [3,19]. For the patients in ICUs, personal and
ICU-related variables were also similar to those described
in data from the Swedish Intensive Care Registry and in
Scandinavia as a whole (ICU population) [20].
Fifth, our approach has led us to conclusions that dif-
fer from those of other articles on this topic, the most
important of which is that both the magnitude of differ-
ences in mean HRQoL and the number of patients who
have, substantially, reduced HRQoLs seem smaller than
previously shown [3,6,21-25]. The reason for this is
mainly the high rate of coexisting conditions among the
patients who had been in ICUs compared with that inthe control group; not only is the rate of coexisting diseases
higher, but the rate of several coexisting conditions within
each patient in the ICU is higher. Significant age and sex
differences exist between patients who were in ICU and in
the control group, and a rather wide “normal” distribution
of HRQoL scores appears in the control group that is sel-
dom fully accounted for in critical care research.
Sixth, also an important finding in the study is that
not only the effect of comorbidity affects the HRQoL
registered after ICU but a significant portion of the pa-
tients that actually report a low HRQoL die in the short
time after ICU care. Also the largest numbers of deaths
are seen before our first measurement at 6 months after
ICU discharge and the HRQoL may be assumed to be
significantly affected, although they were not studied.
Interestingly, we also found that for the study population
that died more than 6 months after ICU (6 to 36 months)
had a low HRQoL after ICU care, but they constituted a
minority. Furthermore, for this group, only minor effects
could be related to psychosocial factors. After stratifying
the remaining patients for comorbidity, these patients
reported an HRQoL close to that of the controls.
Several important issues about the methods that
underlie the analysis have implications for the conclu-
sions. The new approaches are that first, we used a con-
trol group gathered from or near the uptake areas of the
hospitals from which the patients were recruited, and
the coexisting conditions in the control group were
assessed in the same way (self-reports of present disease)
and during a similar time period as the HRQoL data [4].
Although this approach has been used and presented by
us before [3,4,16], what is new is that we have divided
the reference group, depending on the number of coex-
isting conditions into those who are healthy, and those
who have one or more other conditions. This is a better
adjustment for the differences in coexisting comorbidity
burden between groups, but unfortunately, it does not
compensate for differences between type and severity of
diseases, which would be better and should be the aim
in future studies.
Limitations
In evaluating the HRQoL of a group of patients from
ICUs, which group is to be used for comparison to as-
sess the effects of ICU care properly? This is debatable.
Several research workers have used the patients from
ICUs themselves, and their next of kin. In this setting,
patients have been asked to estimate their HRQoL be-
fore they were admitted to the ICU. Although this ap-
proach is logistically appealing, it has been claimed to
overestimate the HRQoL before admission to ICU, and
lead to higher changes in estimates of HRQoL after dis-
charge [5,21]. It has also been shown that the next of kin
underestimate the mental, and overestimate the physical,
Table 4 ICU patients with normal SF-36 scores compared with patients with SF-36 score 2 SD below the reference
group lower level in at least one of the SF-36 eight dimensions for the total group and divided in those with low level














Age (years) 53 (16.1) 52 (15.2) 0.468 49 (16.1) 51 (14.8) 54 (14.6)
No (%) male 284 (51.4) 160 (70.5) <0.001 42 (69) 59 (73) 22 (27) 0.843
No (%) female) 269 (48.6) 67 (29.5) 19 (31) 59 (69) 26 (31)
APACHE II score 14.9 (7.6) 14.8 (7.6) 0.939 12.6 (6.2) 14.6 (7.2) 16.6 (8.5)
Stay in ICU (hours) 125.2 (173.7) 141.5 (189.9) 0.246 117.8 (111.7) 147.5 (175.3) 152.8 (241.3)
Stay in hospital (days) 14.3 (19.5) 15.8 (22.1) 0.363 13.9 (16.6) 15.7 (20.4) 17.3 (26.6)
Time on ventilator (hours) 65.3 (156.7) 69.8 (163.5) 0.722 61.7 (128.2) 58.5 (105.0) 86.3 (222.1)
No (%) deaths during the study 38 (6.9) 38 (16.7) <0.001 6 (9.8) 10 (12.3) 22 (25.9) 0.016
Data are expressed as mean (SD) unless otherwise stated.
All differences in the table between the patients with low level without comorbidity compared with those with low level and one disease are not significant.
All differences in the table between the patients with low level without comorbidity compared with those with low level and more than one disease are not
significant, except for age (P = 0.035), and for APACHE (P = 0.002).
All differences in the table between the patients with low level and one comorbidity compared with those with low level and more than one disease are
not significant.
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a control group from the normal population, may at least
partly explain the altered [5,7,28].
Conclusions
Concerning HRQoL outcome data that we have presented,
one limitation, however, is that the ICU population had to
recall their preexisting diseases in a period of more thanTable 5 Descriptive data for the ICU patients with SF-36 score





(n = 553) (n = 227) P
Marital statea
Married/cohabit 372 (68.1) 124 (54.6)
Single 146 (26.7) 85 (37.4)
Widow/widower 28 (5.1) 14 (6.2)
Employment before ICUa
Employed/leader 261 (49.1) 106 (46.7)
Retired 222 (41.7) 75 (33.0)
Other 49 (9.3) 29 (12.7)
Sick leave before ICU 63 (11.4) 46 (20.3)
Born in Swedena 504 (91.3) 199 (87.7)
Education
Higher than compulsory schoola 353 (64.4) 146 (65.2)
High School/university 131 (24.0) 56 (24.7)
Data are expressed as number (%).
aNot all patients answered the question.
bχ2test between the patients with low level on SF-36 and the patients with normal
cχ2test between those who died and the survivors in the group with low level on S6 months before, whereas the control group did so at the
time of filling out the questionnaire. This may be a factor
that may increase (patient mistakes the ICU disease as a
comorbid state) or decrease, as there might be too few co-
morbid states listed because of memory difficulties. Both
effects are difficult to evaluate. Further, another limitation
is that significant disease-specific symptoms that were
present besides those that can be traced to the regular2 SD under the reference group lower level in at least





valueb Died during the study
(n = 38)
Survived (n = 189) P valuec
0.004 0.694
22 (59.5) 102 (54.8)
12 (32.4) 73 (39.2)
3 (8.1) 11 (5.9)
0.456 0.252
12 (36.4) 94 (53.1)
17 (51.5) 58 (32.8)
4 (12.1) 25 (14.2)
0.001 0.144
0.163 35 (92.1) 164 (87.2) 0.398
0.841 27 (71.1) 119 (64.0) 0.404
0.841 10 (26.3) 46 (24.3) 0.796
level on SF-36.
F-36.
Table 6 Mortality for the total ICU group (n = 780)
Dead Survived P value
With lower SF-36 level than
the reference group, total
38 (16.7) 189 (83.3) <0.001
Dead between 6–12 months 9 (4.0)
Dead between 13–24 months 18 (7.9)
Dead between 25–36 months 11 (4.8)
With normal SF36 level, total 38 (6.9) 515 (93.1)
Dead between 6–12 months 11 (2.0)
Dead between 13–24 months 11 (2.0)
Dead between 25–36 months 16 (2.9)
Data are expressed as number (%). Chi-Square test between the patients with
low level on SF-36 and the patients with normal level on SF-36 in the
total groups.
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the authors (MK), but this was performed in a small num-
ber of patients (<5%) only.
Another technique is to use control groups, and
groups of patients have been approached. Although the-
oretically promising, this solution often lacks the he-
terogeneity of patients in the ICU by comprising only
certain diagnoses and not including emergency care.
With this in mind, a control group based on the general
population from the areas of the local hospitals may be
advantageous. The shortcoming of such a control group
is that it has lower rates of coexisting conditions,Table 7 Descriptive data for the ICU patients who died
during the study period with SF-36 score 2 SD under the
reference group lower level in at least one of the SF-36









Married/cohabit 22 (59.5) 22 (59.5)
Single 12 (32.4) 9 (24.3)
Widow/widower 3 (8.1) 6 (16.2)
Employment before ICUa 0.348
Employed/leader 12 (36.4) 10 (26.3)
Retired 17 (51.5) 27 (71.1)
Other 4 (12.1) 1 (2.6)
Sick leave before ICU 11 (28.9) 2 (85.3) 0.06
Born in Swedena 35 (92.1) 33 (89.2) 0.664
Education
Compulsory schoola 27 (71.1) 22 (57.9) 0.231
High school/university 10 (26.3) 11 (29.7) 0.742
Data are expressed as number (%).
aNot all patients answered the question.possibly a different comorbidity mix, and different age
and sex profiles [3]. These factors may have affected the
conclusions drawn from this study and, although adjust-
ments were made for age and sex and stratification for
coexisting conditions, we lack a disease-specific adjust-
ment, which is a significant shortcoming. Other factors
such as psychosocial issues (for example, abuse) that were
not adjusted for, may also affect the results and should be
addressed as well for a more complete comparison. How-
ever, these factors have previously been found less import-
ant in the regression model of our previous studies [3].
Yet another important issue about the control group is
how to establish what a normal HRQoL is. The figure of −2
SD is often used in other clinical settings, such as within
clinical chemistry, and recently also in psychological re-
search [29-31]. However, we have been unable to find
any previous publications that have used this approach
in HRQoL research related to ICU care. It may also be
argued that nonparametric statistical analysis should be
used. However, in HRQoL research with large groups of
patients (as in the present study), the tradition is to use
parametric statistics [15,32]. We think both these ap-
proaches may affect the results, but related to the exten-
sive previous use of these techniques, such effects may
be claimed to be minor.
A further point of contention is that, in the present
study, an approach by stratifying for the number of dis-
eases (healthy, one other disease, and more than one
other disease) does not take into account the specific ef-
fects of each of the different diseases. A better approach
would then be to adjust for, say, type of disease. Al-
though such an adjustment has recently been made for
HRQoL, this approach has not been evaluated in Europe,
and we therefore did not use it in this study [29]. It would
also be preferable to adjust not only for the specific dis-
ease but also for the severity of each disease. This can be
done for certain conditions such as heart failure and ma-
lignant disease [30,31], but is difficult in the ICU with a
heterogeneous population.
We did not take into account the fact that some pa-
tients obtain a diagnosis of chronic disease during their
stay in ICU or during the follow-up period, and this
should also have been adjusted for. This would affect
mainly the evaluation of the previously healthy patients
in the ICU or those with one or more diseases. They
would be considered to have HRQoL that was falsely re-
duced after they left the ICU, as it would be the effect of
a new disease rather than an effect of the care in the
ICU itself. This suggests that the ICU patients in our
study may have been even less affected by the ICU care.
We chose to use the follow-up data on HRQoL from
the 6 months’ measure to get more observations and
thereby improve power. A plausible effect that could affect
our conclusions is that patients in ICU often do have
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had at 6 months [3]. This would lead to more patients
having poor HRQoL in the evaluation. The improvements
seen at 12 months are most pronounced in the physical
dimensions, but the nature of our data means that such
an effect has not been overlooked, and we think that this
effect is minor and does not alter our conclusions.
Concerning patients lost to follow-up (Figure 1), and
who did not respond at all: it is important to stress that
one of the symptoms of PTSD is avoidance, and such
patients may avoid any reminders of participation. Thus
we cannot exclude that many patients with PTSD-
related symptoms did not answer the questionnaire and
concomitantly may also add to the number of patients
having a low HRQoL after critical illness.
Other limitations of the study include the well-known
risk of underreporting psychological and/or psychiatry-
related problems when using questionnaires. Further, gene-
ralizability issues due to study specifics, such as an upper
age limit, and cultural and economic differences in other
regions of the world, may hamper wider comparisons.
Conclusions
These data show that, after stratifying for coexisting
conditions and adjusting for differences in age and sex,
SF-36 HRQoL scale scores between ICU patients and a
normal population are insignificant. However, as a new
and important finding in this study, we found that in a
subgroup of patients with low scores, the mental di-
mensions were reduced in up to 22% (n = 51) and seen
in patients with more than one comorbidity. This group
was characterized by more often being male, single, on
sick leave before admission to ICU, and also of having
a short survival time after discharge from the ICU.
This group should be an important target for future
interventions.
Key messages
 After stratification for coexisting disease and
adjusting for age and sex, no significant differences
in health-related quality of life were seen between
the ICU group and the reference group 6 months
after discharge from the ICU and hospital.
 About 22% of the ICU patients had SF-36 scores
below the reference group’s lower level (−2 SD).
This effect was seen mainly in the mental
dimensions.
 Characteristics for ICU patients with low
HRQoL (−2 SD or more) were being male,
single, on sick leave before admission to the
ICU, and having a short survival time after
discharge from the ICU.Abbreviations
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